Paper · 39200178
Using microRNAs Networks to Understand Pancreatic Cancer-A Literature Review.
Przybyszewski O and 5 others. Biomedicines, 2024. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Using microRNAs Networks to Understand Pancreatic Cancer-A Literature Review. Papers, record 39200178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39200178
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References189
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,634,527 | WNT signaling pathway and stem cell signaling network. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17634527 | PubMed |
| 2 | 15,806,104 | Combinatorial microRNA target predictions. | Nat Genet | 2005 | https://conductscience.org/library/papers/15806104 | PubMed |
| 3 | 23,359,184 | Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression. | Clin Transl Oncol | 2013 | https://conductscience.org/library/papers/23359184 | PubMed |
| 4 | 24,575,833 | A microRNA meta-signature for pancreatic ductal adenocarcinoma. | Expert Rev Mol Diagn | 2014 | https://conductscience.org/library/papers/24575833 | PubMed |
| 5 | 22,878,649 | MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. | Mod Pathol | 2012 | https://conductscience.org/library/papers/22878649 | PubMed |
| 6 | 24,143,167 | MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster. | PLoS One | 2013 | https://conductscience.org/library/papers/24143167 | PubMed |
| 7 | 30,551,350 | Dysregulation of key microRNAs in pancreatic cancer development. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/30551350 | PubMed |
| 8 | 34,328,099 | Emerging roles of miRNAs in the development of pancreatic cancer. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/34328099 | PubMed |
| 9 | 26,166,038 | miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer. | Int J Oncol | 2015 | https://conductscience.org/library/papers/26166038 | PubMed |
| 10 | 20,885,409 | Targeting microRNAs in cancer: rationale, strategies and challenges. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/20885409 | PubMed |
1 to 10 of 189
See all 189 referencesCited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,914,928 | Prognostic value of microRNA expression in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. | EBioMedicine | 2026 | https://conductscience.org/library/papers/42914928 | PubMed |
| 42,358,587 | Bioinformatics-based Investigation to Unveiling The miRNA-Immunity Axis in The Tumor Microenvironment of Pancreatic Cancer. | F1000Res | 2025 | https://conductscience.org/library/papers/42358587 | PubMed |
| 41,331,086 | Deciphering KRAS inhibitor resistance. | Nat Cell Biol | 2026 | https://conductscience.org/library/papers/41331086 | PubMed |
| 41,329,540 | Serum MicroRNA-196, -200 and -423 Improve Diagnostics and Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis. | Physiol Res | 2025 | https://conductscience.org/library/papers/41329540 | PubMed |
| 39,440,357 | Assessment of the Role of miR-30a-5p on the Proliferation and Apoptosis of Hair Follicle Stem Cells. | J Cosmet Dermatol | 2025 | https://conductscience.org/library/papers/39440357 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CTNNB1 | 1,499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| KRAS | 3,845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| MIR23A | 407,010 | PubTator's text mining | https://conductscience.org/library/genes/407010 | NCBI Gene |
| MIR29C | 407,026 | PubTator's text mining | https://conductscience.org/library/genes/407026 | NCBI Gene |
| PI3 | 5,266 | PubTator's text mining | https://conductscience.org/library/genes/5266 | NCBI Gene |
| TGFB1 | 7,040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39200178
GET https://conductscience.org/api/papers/v1/39200178/references?page=2